| Dr Richard Kadera, MD | |
|
747 Broadway, Seattle, WA 98122-4379 | |
| (206) 215-2520 | |
| (206) 386-3180 |
| Full Name | Dr Richard Kadera |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 29 Years |
| Location | 747 Broadway, Seattle, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003867284 | NPI | - | NPPES |
| 1003867284 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD00037881 (Washington) | Secondary |
| 208M00000X | Hospitalist | MD00037881 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Swedish Issaquah | Issaquah, WA | Hospital |
| Swedish Medical Center | Seattle, WA | Hospital |
| Swedish Medical Center / Cherry Hill | Seattle, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Swedish Health Services | 0244138196 | 834 |
News Archive
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the National Institute of Allergy and Infectious Diseases has exercised its option to advance the development of Soligenix's heat stabilized ricin toxin vaccine, RiVax.
Last-minute, multimillion-dollar deals with wavering Democrats helped secure the support of all 58 Democrats and 2 independents needed to pass the overhaul bill, but they may also set a new bar for future horse trading, Politico reports. Sen. Ben Nelson, D-Neb., "won a provision exempting his state from paying the usual share of costs for new Medicaid patients. The deal critics have dubbed the Cornhusker Kickback is expected to cost the federal government $100 million over 10 years."
Virginia Commonwealth University Massey Cancer Center researchers have found that combining ionizing radiation with a secreted protein that selectively inhibits tumor cell growth and survival can target cancer cells and leave healthy cells alone, perhaps presenting a new approach for treating the deadliest type of brain tumor.
Maria Gaona has been battling diabetes for eight years. Coupled with a family history of the disease, poor eating habits and no exercise regimen, the 64-year-old faces a lifetime of daily medications to control her disease. Fortunately, in 2014, she enrolled in a groundbreaking national research study that has already helped her control her glucose level, lose 16 pounds and regulate her daily medications.
› Verified 8 days ago
| Entity Name | Swedish Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689612954 PECOS PAC ID: 0244138196 Enrollment ID: O20031230000187 |
News Archive
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the National Institute of Allergy and Infectious Diseases has exercised its option to advance the development of Soligenix's heat stabilized ricin toxin vaccine, RiVax.
Last-minute, multimillion-dollar deals with wavering Democrats helped secure the support of all 58 Democrats and 2 independents needed to pass the overhaul bill, but they may also set a new bar for future horse trading, Politico reports. Sen. Ben Nelson, D-Neb., "won a provision exempting his state from paying the usual share of costs for new Medicaid patients. The deal critics have dubbed the Cornhusker Kickback is expected to cost the federal government $100 million over 10 years."
Virginia Commonwealth University Massey Cancer Center researchers have found that combining ionizing radiation with a secreted protein that selectively inhibits tumor cell growth and survival can target cancer cells and leave healthy cells alone, perhaps presenting a new approach for treating the deadliest type of brain tumor.
Maria Gaona has been battling diabetes for eight years. Coupled with a family history of the disease, poor eating habits and no exercise regimen, the 64-year-old faces a lifetime of daily medications to control her disease. Fortunately, in 2014, she enrolled in a groundbreaking national research study that has already helped her control her glucose level, lose 16 pounds and regulate her daily medications.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard Kadera, MD Po Box 25608, Salt Lake City, UT 84125-0608 Ph: (206) 320-4476 | Dr Richard Kadera, MD 747 Broadway, Seattle, WA 98122-4379 Ph: (206) 215-2520 |
News Archive
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the National Institute of Allergy and Infectious Diseases has exercised its option to advance the development of Soligenix's heat stabilized ricin toxin vaccine, RiVax.
Last-minute, multimillion-dollar deals with wavering Democrats helped secure the support of all 58 Democrats and 2 independents needed to pass the overhaul bill, but they may also set a new bar for future horse trading, Politico reports. Sen. Ben Nelson, D-Neb., "won a provision exempting his state from paying the usual share of costs for new Medicaid patients. The deal critics have dubbed the Cornhusker Kickback is expected to cost the federal government $100 million over 10 years."
Virginia Commonwealth University Massey Cancer Center researchers have found that combining ionizing radiation with a secreted protein that selectively inhibits tumor cell growth and survival can target cancer cells and leave healthy cells alone, perhaps presenting a new approach for treating the deadliest type of brain tumor.
Maria Gaona has been battling diabetes for eight years. Coupled with a family history of the disease, poor eating habits and no exercise regimen, the 64-year-old faces a lifetime of daily medications to control her disease. Fortunately, in 2014, she enrolled in a groundbreaking national research study that has already helped her control her glucose level, lose 16 pounds and regulate her daily medications.
› Verified 8 days ago
Dr. Tinsley Coble, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 1550 N 115th Street, Northwest Hospital, Seattle, WA 98133 Phone: 206-368-1849 | |
Philip W Royal, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1100 9th Ave, Seattle, WA 98101 Phone: 206-223-6600 | |
Yordanos T Kahsai, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 925 Seneca St, Seattle, WA 98101 Phone: 206-624-1144 | |
Dr. James Papathanasiou, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1145 Broadway, Seattle, WA 98122 Phone: 206-329-1760 | |
Kristin T Tang, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 747 Broadway, Seattle, WA 98122 Phone: 206-386-6000 Fax: 206-215-6364 | |
Srirama Josyula, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 325 9th Ave, Seattle, WA 98104 Phone: 206-520-5000 | |
David J Horne, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 325 9th Ave, Seattle, WA 98104 Phone: 206-744-3241 |